Trials / Active Not Recruiting
Active Not RecruitingNCT01878344
Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention
Effects of N-acetyl Cysteine on Major Cardiac and Cerebral Events in Patients Undergoing Primary Percutaneous Coronary Intervention Who Have Moderate to High Risk For Contrast Induced Nephropathy
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Suleyman Demirel University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the effects of N-acetyl cysteine on major cardiac and cerebral events in patients undergoing primary percutaneous coronary intervention who have moderate to high risk for contrast induced nephropathy. In a sub-group of patients coronary flow reserve will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NAC | |
| DRUG | Saline |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2018-01-01
- Completion
- 2026-12-01
- First posted
- 2013-06-14
- Last updated
- 2025-05-20
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01878344. Inclusion in this directory is not an endorsement.